ICON Selected by Genomics England to Support the Largest Genome Sequencing Project of Its Kind for Cancer And Rare Diseases
- Written by Reporters
DUBLIN, IRELAND - Media OutReach - Feb 26, 2016 -ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that is has been selected by Genomics England as data management partner for the 100,000 Genomes Project.
A ground-breaking...